Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Industry Preps Proposals To Unseat Japanese Foreign Reference Pricing

This article was originally published in The Gray Sheet

Executive Summary

A group of U.S. medical device manufacturers is working to ensure that potential revisions to Japan's Pharmaceutical Affairs Law do not increase approval times for new products
Advertisement

Related Content

“New Phase” Of Japanese Health Care Opens Door To U.S. Manufacturers
“New Phase” Of Japanese Health Care Opens Door To U.S. Manufacturers
Established Firms Have Most To Gain From Japanese Device Revisions
Established Firms Have Most To Gain From Japanese Device Revisions
Japan Reimbursement Guidelines Allow Semiannual Review For C1 Devices
Advertisement
UsernamePublicRestriction

Register

MT016425

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel